TY - JOUR
T1 - The Manaus Declaration
T2 - Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group
AU - The International Histoplasmosis Advocacy Group (iHAG)
AU - Caceres, Diego H.
AU - Adenis, Antoine
AU - de Souza, João Vicente Braga
AU - Gomez, Beatriz L.
AU - Cruz, Katia Santana
AU - Pasqualotto, Alessandro C.
AU - Ravasi, Giovanni
AU - Perez, Freddy
AU - Chiller, Tom
AU - de Lacerda, Marcus Vinicius Guimarares
AU - Nacher, Mathieu
N1 - Funding Information:
The second meeting of the international Histoplasmosis Advocacy Group (iHAG 2019) was co-organized by the International Histoplasmosis Advocacy Group (iHAG), Instituto Nacional de Pesquisas da Amazôna (INPA-Brazil), Fundação de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD-Brazil), Pan American Health Organization (PAHO)/World Health Organization (WHO), and the Centers for Disease Control and Prevention (CDC). The meeting was supported by the Fundação de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (Grant No 005/2017 Program to Support the Holding of Scientific and Technological Events in the State of Amazonas—PAREV), Fundação Oswaldo Cruz (Fiocruz), Global Action Fund for Fungal Infections (GAFFI), International Society for Human and Animal Mycology (ISHAM), Mycoses Study Group Education and Research Consortium (MSGERC), Centre d'Investigation Clinique Antilles Guyane (Inserm CIC1424) of the Centre Hospitalier de Cayenne, Universidad del Rosario, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), and Santa Casa de Misericórdia de Porto Alegre.
Publisher Copyright:
© 2019, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Purpose of Review: The aim of this report is to summarize the conclusions of the II Regional Meeting on Histoplasmosis in the Americas held in Manaus, Brazil, on March 22–24, 2019. Recent Findings: Persons living with advanced HIV are at high risk for developing histoplasmosis. Clinical signs and symptoms of this disease are often non-specific, making it difficult to establish a diagnosis. Although with the recent technological advances, in vitro diagnostics and medicines for histoplasmosis are often not available in many regions around the world. In addition, histoplasmosis is often not included in HIV care and treatment programs, resulting in inadequate health system planning and missed opportunities to save lives. Summary: The II Regional Meeting on Histoplasmosis in the Americas gathered a multidisciplinary audience. Developed recommendations to be included in the WHO guidelines for diagnosis and treatment of histoplasmosis in advanced HIV were the product of this meeting, and guidelines are aimed to be published in early 2020.
AB - Purpose of Review: The aim of this report is to summarize the conclusions of the II Regional Meeting on Histoplasmosis in the Americas held in Manaus, Brazil, on March 22–24, 2019. Recent Findings: Persons living with advanced HIV are at high risk for developing histoplasmosis. Clinical signs and symptoms of this disease are often non-specific, making it difficult to establish a diagnosis. Although with the recent technological advances, in vitro diagnostics and medicines for histoplasmosis are often not available in many regions around the world. In addition, histoplasmosis is often not included in HIV care and treatment programs, resulting in inadequate health system planning and missed opportunities to save lives. Summary: The II Regional Meeting on Histoplasmosis in the Americas gathered a multidisciplinary audience. Developed recommendations to be included in the WHO guidelines for diagnosis and treatment of histoplasmosis in advanced HIV were the product of this meeting, and guidelines are aimed to be published in early 2020.
UR - http://www.scopus.com/inward/record.url?scp=85075916707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075916707&partnerID=8YFLogxK
U2 - 10.1007/s12281-019-00365-3
DO - 10.1007/s12281-019-00365-3
M3 - Review article
AN - SCOPUS:85075916707
SN - 1936-3761
VL - 13
SP - 244
EP - 249
JO - Current Fungal Infection Reports
JF - Current Fungal Infection Reports
IS - 4
ER -
